Press Releases

Press Releases

Patients For Affordable Drugs Responds to Trump’s Announcement On Tariffs

WASHINGTON, DC – Following President Trump’s announcement of sweeping tariffs of up to 100% on imported brand-name prescription drugs and their ingredients, Patients For Affordable Drugs CEO Merith Basey released the following statement: “While these tariffs aim to pressure pharmaceutical corporations into U.S. manufacturing and Most Favored Nation agreements, the current MFN deals remain opaque and voluntary, and have […]

Press Releases

P4AD Expands Board Leadership, Strengthening Expertise and Momentum in the Fight to Lower Drug Prices

WASHINGTON, D.C. — Patients For Affordable Drugs today announced the addition of new leaders to its board of directors, further strengthening the organization’s expertise and continued growth. “Our new board members bring a depth of knowledge across medicine, law, public health, and business, along with patient experience — exactly the expertise this fight demands,” said Merith Basey, CEO […]

Press Releases

New P4AD Analysis: Pharma Hikes Prices on Cancer Drugs, While Lobbying to Obstruct Reform

Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs released a new analysis showing that drugmakers are raising prices on lifesaving oncology medications while lobbying to delay Medicare Drug Price Negotiation programs — reinforcing a pattern of price hikes alongside efforts to weaken reforms. In the […]

Press Releases

New P4AD Analysis: Drugmakers Hike Prices Following Reconciliation Package that Weakened Medicare Negotiation for Rare Disease Drugs

Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs is releasing a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package, which weakened […]

Press Releases

P4AD Files Sixth Amicus Brief Defending Medicare Negotiation, Amplifying Patient Voices Against Teva’s Appeal

WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) filed its sixth patient-centered amicus brief defending the Medicare Negotiation Program, this time in the District of Columbia U.S. Court of Appeals, where Teva Pharmaceuticals is appealing its failed attempt to strike down the program. The brief underscores the real-world impact of lower prices for patients and responds to legal […]

Press Releases

New P4AD Analysis: Pharma Hikes HIV Drug Prices As Industry Pushes Bill to Lock In Higher Prices for Years

Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — A new analysis from Patients For Affordable Drugs spotlights a troubling pattern: pharmaceutical companies are raising prices on HIV medications, while simultaneously lobbying Congress to pass the harmful EPIC Act, which would delay Medicare drug price negotiations that could lower prices on […]

Press Releases

ICYMI: Majority of Americans Worried about Affording Prescription Drugs, New Polling Confirms

WASHINGTON, D.C. — New polling from KFF underscores just how deeply the high cost of prescription drugs is harming Americans across the country. Findings include: 59% of U.S. adults are worried about their ability to pay for prescription drugs, either for themselves or their families. This is the largest share since KFF began polling the question in 2018. […]

Press Releases

STATEMENT: Patients For Affordable Drugs Responds To AbbVie Pharmaceuticals Lawsuit To Stop Medicare Negotiation

Marks the 11th lawsuit filed by Big Pharma and its allies to undermine Medicare Drug Price Negotiation at the expense of patients WASHINGTON, D.C. — Just two weeks after Botox and Botox Cosmetic were named as drugs to be included in the third round of Medicare Drug Price Negotiations, manufacturer AbbVie, has filed a lawsuit in the U.S. District Court […]